Resmed's top three insider shareholders as of April 28, 2026 are Michael J. Farrell (Chairman And Ceo, 466.22K shares), Robert Andrew Douglas (President And Coo, 250.53K shares), David Pendarvis (Chief Administrative Officer, 89.73K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Michael J. Farrell | Chairman And Ceo | 466,223 | 0 | 09 Apr, 2026 |
| Robert Andrew Douglas | President And Coo | 0 | 250,526 | 16 Aug, 2023 |
| David Pendarvis | Chief Administrative Officer | 89,729 | 0 | 06 Jun, 2023 |
| Brett Sandercock | Chief Financial Officer | 83,495 | 0 | 02 Apr, 2026 |
| Brett Sandercock | Chief Financial Officer | 83,495 | 0 | 02 Apr, 2026 |
| Peter C Farrell | - | 77,552 | 0 | 18 Nov, 2025 |
| James Hollingshead | President, Sleep Business | 76,721 | 0 | 01 Dec, 2021 |
| Peter C Farrell | Chairman Of The Board | 60,773 | 0 | 02 Apr, 2026 |
| Justin Leong | Chief Product Officer | 29,028 | 0 | 21 Nov, 2025 |
| Ronald R Taylor | - | 24,771 | 0 | 21 Nov, 2025 |
| Ronald R Taylor | - | 24,771 | 0 | 21 Nov, 2025 |
| Richard Sulpizio | - | 17,796 | 0 | 21 Nov, 2024 |
| Richard Sulpizio | - | 17,796 | 0 | 21 Nov, 2024 |
| Carol Burt | - | 0 | 14,892 | 24 May, 2024 |
| Robert Andrew Douglas | President And Coo | 13,849 | 0 | 20 Nov, 2023 |
| Inc Resmed | - | 13,823 | 0 | 22 Nov, 2021 |
| Harjit Gill | - | 10,940 | 0 | 24 Nov, 2025 |
| Karen Drexler | - | 10,602 | 0 | 24 Nov, 2025 |
| Lucile Blaise | President, Sleep Rc Business | 10,305 | 0 | 15 Nov, 2023 |
| Kaushik Ghoshal | Chief Commercial Officer, Saas | 9,725 | 0 | 11 Mar, 2025 |
| Michael J Rider | Global General Counsel | 9,691 | 0 | 05 Feb, 2026 |
| Michael J Rider | Global General Counsel | 9,691 | 0 | 05 Feb, 2026 |
| Kaushik Ghoshal | Chief Commercial Officer, Saas | 0 | 9,628 | 01 Nov, 2024 |
| Desney Tan | - | 6,002 | 0 | 24 Nov, 2025 |
| Desney Tan | - | 6,002 | 0 | 24 Nov, 2025 |
| John Hernandez | - | 5,118 | 0 | 24 Nov, 2025 |
| Witte Jan De | - | 4,989 | 0 | 22 Nov, 2021 |
| Witte Jan De | - | 4,261 | 0 | 26 Nov, 2025 |
| Michael J. Farrell | Chief Executive Officer | 0 | 3,880 | 01 Dec, 2021 |
| Christopher Delorefice | - | 2,423 | 0 | 21 Nov, 2025 |
| Carol Burt | - | 2,156 | 0 | 24 Nov, 2025 |
| Michael J. Farrell | Chief Executive Officer | 0 | 2,090 | 27 Nov, 2024 |
| John Hernandez | - | 2,078 | 0 | 18 Nov, 2022 |
| Nicole Mowad-Nassar | - | 777 | 0 | 24 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Apr, 2026 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 07 Apr, 2026 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $225.50 | 466,223 | D | S |
| 07 Apr, 2026 | Michael J. Farrell | ResMed Common Stock Options | D | 4,991 | $0.00 | 34,939 | D | M |
| 01 Apr, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $224.31 | 83,495 | D | S |
| 01 Apr, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $224.31 | 83,495 | D | S |
| 01 Apr, 2026 | Peter C Farrell | ResMed Common Stock | D | 2,000 | $225.00 | 60,773 | D | S |
| 09 Mar, 2026 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 09 Mar, 2026 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $251.03 | 466,223 | D | S |
| 09 Mar, 2026 | Michael J. Farrell | ResMed Common Stock Options | D | 4,991 | $0.00 | 39,930 | D | M |
| 04 Mar, 2026 | Peter C Farrell | ResMed Common Stock | D | 2,000 | $260.22 | 62,773 | D | S |
| 02 Mar, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $254.30 | 84,495 | D | S |
| 02 Mar, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $254.30 | 84,495 | D | S |
| 09 Feb, 2026 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 09 Feb, 2026 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $273.78 | 466,223 | D | S |
| 09 Feb, 2026 | Michael J. Farrell | ResMed Common Stock Options | D | 4,991 | $0.00 | 44,921 | D | M |
| 04 Feb, 2026 | Peter C Farrell | ResMed Common Stock | D | 2,000 | $251.31 | 64,773 | D | S |
| 04 Feb, 2026 | Michael J Rider | ResMed Common Stock | D | 50 | $260.00 | 9,691 | D | S |
| 04 Feb, 2026 | Michael J Rider | ResMed Common Stock | D | 50 | $260.00 | 9,691 | D | S |
| 02 Feb, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $257.03 | 85,495 | D | S |
| 02 Feb, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $257.03 | 85,495 | D | S |